Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Hodgkin Disease 7 Multiple Myeloma 6 Leukemia 6 Neoplasm Metastasis 5 Myelodysplastic Syndromes 5 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Prostatic Neoplasms 4 Neoplasms 4 Leukemia, Myeloid, Acute 4 Leukemia, Myeloid, Accelerated Phase 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Graft vs Host Disease 4 Blast Crisis 4 Sarcoma 3 Primary Myelofibrosis 3 Pancreatic Neoplasms 3 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma, Large B-Cell, Diffuse 3 Burkitt Lymphoma 3 Breast Neoplasms 3 Waldenstrom Macroglobulinemia 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms, Plasma Cell 2 Myeloproliferative Disorders 2 Lymphoma, Mantle-Cell 2 Lung Neoplasms 2

Interventions

Cyclophosphamide 12 aldesleukin 9 fludarabine 8 fludarabine phosphate 7 pembrolizumab 6 Ipilimumab 5 Interleukin-2 5 Nivolumab 4 dabrafenib 2 Vemurafenib 2 Biopsy 2 Aminolevulinic Acid 2 varlilumab 1 trametinib 1 tilsotolimod 1 spartalizumab 1 sotigalimab 1 sonidegib 1 smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1 glembatumumab vedotin 1 eprenetapopt 1 epacadostat 1 encorafenib 1 cemiplimab 1 cabozantinib 1 binimetinib 1 bempegaldesleukin 1 abobotulinumtoxinA 1 X-Rays 1 Tranexamic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Skin Neoplasms × Sirolimus × Clear all

NCT00866684 2025-03-14

PROSKIN

Charite University, Berlin, Germany

Phase 4 Terminated

44 enrolled 7 charts

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡